Published: Guidance, quality standards and advice
Showing 181 to 190 of 1904
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Stroke rehabilitation in adults | NG236 | ||
| Glofitamab for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic treatments | TA927 | ||
| Virtual ward platform technologies for acute respiratory infections | HTE13 | ||
| Thyroid disease: assessment and management | NG145 | ||
| Bimekizumab for treating axial spondyloarthritis | TA918 | ||
| Pegunigalsidase alfa for treating Fabry disease | TA915 | ||
| Bimekizumab for treating active psoriatic arthritis | TA916 | ||
| Urinary incontinence in neurological disease: assessment and management | CG148 | ||
| Ovarian cancer: recognition and initial management | CG122 | ||
| Suspected cancer: recognition and referral | NG12 |